Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

India’s Pitch To Oppose “Automatic Patenting” Gets Louder With Moves To Seek China’s Support

This article was originally published in PharmAsia News

Executive Summary

MUMBAI - India is mobilizing support from China in countering a move by the World Intellectual Property Organization and the U.S. for a global patenting system that, according to India, is "pushing for the automatic grant of patents in all member states." Senior officials from Indian pharmaceutical companies and associations are currently on a visit to Beijing to persuade Chinese officials on the implications of the proposed new system

You may also be interested in...



Indian Pharma Lobby Begins Fresh Offensive For Cap On Foreign Investments Into Domestic Companies

MUMBAI - As India's commerce and finance ministries wrangle over the viability of capping investments by global pharmaceutical companies into Indian generic firms, the Indian Pharmaceutical Alliance led a new offensive urging the government to tighten investment regulations

Indian Pharma Lobby Begins Fresh Offensive For Cap On Foreign Investments Into Domestic Companies

MUMBAI - As India's commerce and finance ministries wrangle over the viability of capping investments by global pharmaceutical companies into Indian generic firms, the Indian Pharmaceutical Alliance led a new offensive urging the government to tighten investment regulations

Challenges To The Indian Drug Industry Subtle, Manifold and More Potent Now, Pharma Lobby Tells Government

MUMBAI - A spate of adverse moves by developed countries and international agencies in the past year have been most challenging for the Indian drug industry, says the Indian Pharmaceutical Alliance - the lobby of top Indian generic drug makers

Latest News
UsernamePublicRestriction

Register

SC071586

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel